Antigens, Surface

Antigens, Surface
Accession Number

Antigens on surfaces of cells, including infectious or foreign cells or viruses. They are usually protein-containing groups on cell membranes or walls and may be isolated.

DrugDrug Description
AdecatumumabInvestigated for use/treatment in breast cancer and prostate cancer.
PRO-542Investigated for use/treatment in acquired immune deficiency syndrome (AIDS) and aids-related infections, HIV infection, and pediatric indications.
Axicabtagene ciloleucelA CAR T-cell therapy used to treat adults with large B-cell lymphomas and follicular lymphoma.
Eftilagimod alfaEftilagimod alfa is under investigation in clinical trial NCT02614833 (IMP321 (Eftilagimod Alpha) as Adjunctive to a Standard Chemotherapy Paclitaxel Metastatic Breast Carcinoma).
Nelipepimut-SInvestigated for use/treatment in prostate cancer and breast cancer.
ReltecimodReltecimod is under investigation in clinical trial NCT02469857 (Phase III Efficacy and Safety Study of AB103 in the Treatment of Patients With Necrotizing Soft Tissue Infections).
GI-6207Not Annotated
Drugs & Drug Targets
PRO-542Free fatty acid receptor 4target
Axicabtagene ciloleucelB-lymphocyte antigen CD19target
Nelipepimut-SHLA class I histocompatibility antigen, A-2 alpha chaintarget
Nelipepimut-SHLA class I histocompatibility antigen, A-3 alpha chaintarget